NWMP
NVO

Noble Wealth Management PBC’s Novo Nordisk NVO Stock Holding History

Noble Wealth Management PBC’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$38 Sell
1
-19
-95% -$876 ﹤0.01% 783
2026
Q2 		$959 Buy
+20
New +$859 ﹤0.01% 716
2025
Q1 		– Sell
-67
Closed -$5.76K – 510
2024
Q4 		$5.76K Buy
+67
New +$7.25K ﹤0.01% 391

Other funds holding NVO

GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
MCP
Martin Capital Partners Eugene, Oregon $279M AUM 18.87% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EIA
Eastover Investment Advisors Charlotte, North Carolina $257M AUM 14.8% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
NFGCM
Norman Fields Gottscho Capital Management New York $329M AUM 22.06% 1-Year Est. Return
BFA
Benedict Financial Advisors Atlanta, Georgia $504M AUM 20.67% 1-Year Est. Return
HWA
Heartwood Wealth Advisors Richmond, Virginia $1.27B AUM 11.08% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
RI
Ridgewood Investments Springfield, New Jersey $271M AUM

Noble Wealth Management PBC's NVO Position: Q3 2026 in Review

Noble Wealth Management PBC reduced its Novo Nordisk (NVO) stake by 95% in Q3 2026, selling an estimated $876 and leaving 1 share worth $38. The position accounts for ﹤0.01% of the portfolio, ranked #783.

Noble Wealth Management PBC first reported a position in NVO in Q4 2024 and has held it in 3 quarters since. The position peaked at $5.76K in Q4 2024. 64 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • Noble Wealth Management PBC held 1 share of Novo Nordisk worth $38 as of Q3 2026.
  • Noble Wealth Management PBC sold 19 Novo Nordisk shares in Q3 2026, an estimated $876.
  • Novo Nordisk made up ﹤0.01% of Noble Wealth Management PBC's portfolio in Q3 2026, its #783 holding.
  • Noble Wealth Management PBC first reported a position in Novo Nordisk in Q4 2024 and has held it in 3 quarters since.
  • Noble Wealth Management PBC's Novo Nordisk position peaked at $5.76K in Q4 2024.
  • 64 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Noble Wealth Management PBC's 13F filing for Q3 2026, filed 1 Oct 2026.